Published in J Neurol Neurosurg Psychiatry on March 01, 1988
Pure psychic akinesia with bilateral lesions of basal ganglia. J Neurol Neurosurg Psychiatry (1984) 1.49
Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry (1971) 1.36
Long-term thyroxine treatment and bone mineral density. Lancet (1992) 3.67
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Medical audits. J R Coll Physicians Lond (1980) 3.15
Problems in assessing contents of metered dose inhalers. BMJ (1993) 3.07
Validity of the Eating Disorder Examination Questionnaire (EDE-Q) in screening for eating disorders in community samples. Behav Res Ther (2004) 2.96
Medical audit in general medicine. J R Coll Physicians Lond (1981) 2.89
Hypercalcaemia in hospital patients. Clinical and diagnostic aspects. Lancet (1981) 2.82
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Hypercalcaemia--a hospital survey. Q J Med (1980) 2.50
Cardiopulmonary resuscitation: who makes the decision? BMJ (1994) 2.34
Relation between socioeconomic status, employment, and health during economic change, 1973-93. BMJ (1996) 2.33
Eating Disorder Examination Questionnaire (EDE-Q): norms for young adult women. Behav Res Ther (2006) 2.30
The development of a radioimmunoassay for the measurement of human plasma arginine vasopressin. Clin Endocrinol (Oxf) (1977) 2.10
Mineralization of collagen may occur on fibril surfaces: evidence from conventional and high-voltage electron microscopy and three-dimensional imaging. J Struct Biol (1997) 2.02
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Sickle cell hepatopathy. Hepatology (2001) 1.85
Brain ischemia and reperfusion activates the eukaryotic initiation factor 2alpha kinase, PERK. J Neurochem (2001) 1.81
Starch-Ampicillin Agar for the Quantitative Detection of Aeromonas hydrophila. Appl Environ Microbiol (1985) 1.72
Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl (1996) 1.72
Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry (2003) 1.70
Surgical treatment of primary hyperparathyroidism in the elderly. Br Med J (1980) 1.69
Hypomagnesaemic tetany associated with prolonged treatment with aminoglycosides. Br Med J (Clin Res Ed) (1986) 1.68
Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) (1974) 1.63
Structure of bacterial flagellar filaments at 11 A resolution: packing of the alpha-helices. J Mol Biol (1995) 1.63
Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) (1993) 1.61
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Formal complaints against general practitioners: a study of 1000 cases. Br J Gen Pract (1991) 1.57
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
The misting characteristics of spectacle lenses. Ophthalmic Physiol Opt (1996) 1.49
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett (1990) 1.47
HLA linkage with familial vesicoureteral reflux and familial pelvi-ureteric junction obstruction. Tissue Antigens (1989) 1.46
Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci (1999) 1.45
Influence of surgeon's experience on speech outcome in cleft lip and palate. Lancet (1999) 1.44
Gender inequalities in health: social position, affective disorders and minor physical morbidity. Soc Sci Med (1993) 1.44
Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res (2000) 1.44
Hypercalcaemia: changing causes over the past 10 years. BMJ (1992) 1.43
Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci (2008) 1.43
Migraine after bone-marrow transplantation. Lancet (1989) 1.43
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
Submandibular duct sialolith of unusual size and shape. J Oral Surg (1975) 1.31
Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev (2003) 1.30
Objective and subjective bulimic episodes in the classification of bulimic-type eating disorders: another nail in the coffin of a problematic distinction. Behav Res Ther (2010) 1.29
Self-report versus interview assessment of purging in a community sample of women. Eur Eat Disord Rev (2007) 1.29
Giant invasive prolactinoma: a case report and review of nine further cases. Q J Med (1990) 1.28
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Sexual difficulties of chronic pain patients. Clin J Pain (2001) 1.25
Long-term treatment of parkinsonism with bromocriptine. Lancet (1978) 1.24
Development and validation of an immunoradiometric assay of parathyrin-related protein in unextracted plasma. Clin Chem (1991) 1.22
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J (2001) 1.21
Sexually transmitted infections in women who have sex with women. Sex Transm Infect (2004) 1.21
Systematic review of outpatient services for chronic pain control. Health Technol Assess (1997) 1.19
Sexual behaviour of lesbians and bisexual women. Sex Transm Infect (2003) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Xenobiotic metabolism in motor neuron disease. Lancet (1988) 1.16
Xenobiotic metabolism in Parkinson's disease. Neurology (1989) 1.16
Water disturbances in patients treated with oral lithium carbonate. Ann Intern Med (1978) 1.16
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Use of a behavioural programme in the first 3 months to prevent infant crying and sleeping problems. J Paediatr Child Health (2001) 1.13
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 4: outcome comparisons, training, and conclusions. Cleft Palate Craniofac J (2001) 1.12
Comparative study of available medical therapy for hypercalcemia of malignancy. Am J Med (1983) 1.12
Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein. BMJ (1990) 1.11
Assessing quality of life in eating disorder patients. Qual Life Res (2005) 1.10
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol (1990) 1.10
Parathyroid localization by angiographic techniques in patients with previous neck surgery. Br J Radiol (1973) 1.09
Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia. Lancet (1977) 1.09
Preoperative localization of abnormal parathyroid tissue. Cumulative experience with venous sampling and arteriography. Am J Med (1973) 1.09
The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain (1994) 1.08
Continuities of common behaviour problems in preschool children. J Child Psychol Psychiatry (1984) 1.08
The role of mithramycin in the management of Paget's disease. Metab Bone Dis Relat Res (1981) 1.08
Spinal cord stimulation and the relief of chronic pain. J Neurol Neurosurg Psychiatry (1987) 1.06
In vivo and in vitro precision for bone density measured by dual-energy X-ray absorption. Osteoporos Int (1991) 1.06
Disordered eating behaviours and cognitions in young women with obesity: relationship with psychological status. Int J Obes (Lond) (2006) 1.04
Mode of delivery, but not questionnaire length, affected response in an epidemiological study of eating-disordered behavior. J Clin Epidemiol (2004) 1.04
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 1: background and methodology. Cleft Palate Craniofac J (2001) 1.03
Development of the sheep ovary during fetal and early neonatal life and the effect of fecundity genes. J Reprod Fertil Suppl (1995) 1.02
Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry (1988) 1.02
Lesbians and cervical screening. Br J Gen Pract (2000) 1.01
Smoking habits of Florida physicians revisited. JFMA (1972) 1.01
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer (1970) 1.01
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol (1999) 1.01
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science (1979) 1.01
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut (2005) 1.00
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene (2012) 1.00
Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 1.00
Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection. Soc Sci Med (1997) 0.99
Hypercalcaemia and malignancy. Ann Clin Biochem (1976) 0.99
The investigation of lactalbumin as a possible marker for human breast cancer. Eur J Cancer (1979) 0.99
Motoneurone disease as manifestation of pesticide toxicity. Lancet (1987) 0.99
Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report. Clin Endocrinol (Oxf) (1985) 0.99
Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet (1996) 0.98
Group interpersonal psychotherapy for postnatal depression: a pilot study. Arch Womens Ment Health (2005) 0.98
Derepression of synthesis of the aminoacyl-transfer ribonucleic acid synthetases for the branched-chain amino acids of Escherichia coli. J Bacteriol (1974) 0.98
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol (2001) 0.98
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Women with bulimic eating disorders: When do they receive treatment for an eating problem? J Consult Clin Psychol (2009) 0.97
Ontogeny of steroidogenesis in the fetal sheep gonad. Biol Reprod (2001) 0.97
Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer (1994) 0.97